Metabolomics of cerebrospinal fluid reveals candidate diagnostic biomarkers to distinguish between spinal muscular atrophy type II and type III
CNS Neurosci Ther. 2024 Apr;30(4):e14718. doi: 10.1111/cns.14718. ABSTRACT AIMS: Classification of spinal muscular atrophy (SMA) is associated with the clinical prognosis; however, objective classification markers …